核糖核酸（RNA）標記市場：按類型、應用、最終用戶和地區分類。

Ribonucleic Acid (RNA) Markers Market, by Type, by Application, by End User by Region

出版日期: 2026年04月29日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

核糖核酸（RNA）標記市場預計在2026年達到2.926億美元，預計到2033年將達到5.334億美元。預計從2026年到2033年，其複合年成長率將達到9.0%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	2.926億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	9.00%	2033年市場規模預測：	5.334億美元

分子標記（也稱為遺傳標記）是與基因組或RNA庫中特定位置相關的DNA或RNA片段。在分子生物學和生物技術領域，分子標記用於從未知核酸序列庫中識別特定的DNA或RNA序列。 RNA標記用於估算單鏈RNA的大小。例如，生物技術和分子生物學酶及其他產品的生產商Promega公司提供適用於估算單鏈RNA大小的RNA標記，其在乙二醛或甲醛瓊脂糖凝膠電泳中的適用範圍為0.28至6.58 kb。這些RNA標記由九種RNA轉錄物組成，這些轉錄本在體外由特定模板合成，其大小分別為281、623、955、1383、1908、2604、3638、4981和6583個鹼基。這些標記物可以透過溴化乙錠染色來顯現。

市場動態

市場參與者正致力於擴大生產設施，預計這將推動全球核糖核酸（RNA）標記物市場在預測期內的成長。例如，2023年1月20日，總部位於美國的製藥和生物技術公司Moderna宣布，計劃擴大其在加拿大的生產能力，這是該公司與加拿大政府為期10年的夥伴關係的一部分，旨在加強加拿大應對疫情的能力。此外，出於同樣的原因，該公司還計劃擴大在澳洲的生產設施。同時，該公司也計劃擴大在肯亞的生產設施。預計澳洲的工廠每年將生產多達1億劑mRNA疫苗，其中包括用於治療呼吸道感染疾病的疫苗。肯亞的新工廠預計每年將至少生產5億劑疫苗。

本研究的主要特點：

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究基於以下參數分析了全球核糖核酸 (RNA) 標記市場的主要參與者：公司概況、產品系列、關鍵亮點、財務表現和策略。本研究涵蓋的主要參與者包括：安捷倫科技公司 (Agilent Technologies, Inc.)、牛津基因技術知識產權有限公司 (Oxford Gene Technology IP Limited)、珀金埃爾默公司 (PerkinElmer Inc.)、歐陸科技 (Eurofins Scientific)、羅氏公司 (F. Hoffmann-La Roche Ltd.、 Biolabs)、普羅米加公司 (Promega Corporation)、默克集團 (Merck KGaA)、寶生物公司 (Takara Bio Inc.)、Abnova Corporation、賽默飛世爾科技公司 (Thermo Fisher Scientific)、安捷倫科技公司 (Agilent Technologies)、凱傑銀行 (QIAGEN)、Bio-Rad Laborator、Zakor、Tirak Services。
透過利用本報告中提出的見解，各公司的行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
全球核糖核酸（RNA）標記市場報告的目標受群眾外包括該行業的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用分析全球核糖核酸 (RNA) 標記市場中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

Agilent Technologies, Inc.
Oxford Gene Technology IP Limited
PerkinElmer Inc.
Eurofins Scientific
F. Hoffmann-La Roche Ltd
NextGen Life Sciences Private Limited
bioMerieux SA
New England Biolabs
Promega Corporation
Merck KGaA
Takara Bio Inc.
Abnova Corporation
Thermo Fisher Scientific Inc.
QIAGEN
Bio-Rad Laboratories, Inc.
Lonza
CardioNet
ZOLL Medical Corporation
Hill-Rom Services, Inc.

第9章

調查方法
關於本公司

簡介目錄

Product Code: CMI5584

Ribonucleic Acid (RNA) Markers Market is estimated to be valued at USD 292.6 Mn in 2026 and is expected to reach USD 533.4 Mn by 2033, growing at a compound annual growth rate (CAGR) of 9.0% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 292.6 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	9.00%	2033 Value Projection:	USD 533.4 Mn

A molecular marker (identified as genetic marker) is a fragment of DNA or RNA, which is associated with a certain location within the genome or RNA Pool. Molecular markers are used in molecular biology and biotechnology to identify a particular sequence of DNA or RNA in a pool of unknown nucleic acid sequence. RNA markers are used for the size estimation of single stranded RNA. For example, Promega Corporation, manufacturer of enzymes and other products for biotechnology and molecular biology is offering RNA markers and these markers are suitable for size estimation of single-stranded RNA from 0.28-6.58kb in glyoxal or formaldehyde-agarose gels. The RNA markers consist of a ladder of nine RNA transcripts that are synthesized in vitro from specific templates. The sizes are 281, 623, 955, 1,383, 1,908, 2,604, 3,638, 4,981 and 6,583 bases. The markers can be visualized by ethidium bromide staining.

Market Dynamics

Market players are indulged in expansion of manufacturing facilities, which is expected to drive the growth of the global ribonucleic acid (RNA) markers market, over the forecast period. For instance, on 20 January 2023, Moderna, Inc., an U.S. based pharmaceutical and biotechnology company, is planning to expand its manufacturing capacity in Canada, as part of a 10-year partnership with the Canadian government in order to strengthen the company's pandemic response. Moreover, the company is also planning to expand its manufacturing facility in Australia, for the same reason as above. The company is also planning to expand its manufacturing facility in Kenya. The Australian facility is expected to produce up to 100 million mRNA vaccine doses annually, including for respiratory infections. The new facility in Kenya is expected to produce at least of 500 million vaccine doses per year.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global ribonucleic acid (RNA) markers market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies Key companies covered as a part of this study include Agilent Technologies, Inc., Oxford Gene Technology IP Limited, PerkinElmer Inc., Eurofins Scientific, F. Hoffmann-La Roche Ltd, NextGen Life Sciences Private Limited, bioMerieux SA, New England Biolabs, Promega Corporation, Merck KGaA, Takara Bio Inc., Abnova Corporation, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., QIAGEN, Bio-Rad Laboratories, Inc., Lonza, CardioNet, ZOLL Medical Corporation and Hill-Rom Services, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global ribonucleic acid (RNA) markers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global ribonucleic acid (RNA) markers market

Detailed Segmentation:

Global Ribonucleic Acid (RNA) Markers Market, By Type (Revenue, USD Mn, 2021 - 2033)
Prestained Markers
Unstained Markers
Specialty Markers
Global Ribonucleic Acid (RNA) Markers Market, By Application (Revenue, USD Mn, 2021 - 2033)
Nucleic Acid Applications
Proteomics Applications
Global Ribonucleic Acid (RNA) Markers Market By End User (Revenue, USD Mn, 2021 - 2033)
Research Centers
Pharmaceutical and Biotechnology Companies
Others ( Academic Institutes, Forensic Laboratory and Others)
Global Ribonucleic Acid (RNA) Markers Market, By Region (Revenue, USD Mn, 2021 - 2033)
North America
- By Country:
  - U.S.
  - Canada
Latin America
- By Country:
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- By Country:
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- By Country
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- By Country:
  - GCC
  - Israel
  - Rest of Middle East
Africa
- By Country/Region:
  - South Africa
  - Central Africa
  - North Africa
Company Profiles
Agilent Technologies, Inc.*
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
Oxford Gene Technology IP Limited
PerkinElmer Inc.
Eurofins Scientific
F. Hoffmann-La Roche Ltd
NextGen Life Sciences Private Limited
bioMerieux SA
New England Biolabs
Promega Corporation
Merck KGaA
Takara Bio Inc.
Abnova Corporation
Thermo Fisher Scientific Inc.
QIAGEN
Bio-Rad Laboratories, Inc.
Lonza, CardioNet
ZOLL Medical Corporation
Hill-Rom Services, Inc.

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
Product Launches
Market Trends
Merger, Acquisition, Collaborations
Regulatory Guideline and Compliances
Key Developments
PEST Analysis
PORTER's Analysis
Technology Landscape
Pricing Analysis
Brand Analysis
Investments and Funding
Facility Expansions

4. Global Ribonucleic Acid (RNA) Markers Market, By Type, 2021 - 2033, (US$ Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Prestained Markers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Unstained Markers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Specialty Markers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)

5. Global Ribonucleic Acid (RNA) Markers Market, By Application, 2021 - 2033, (US$ Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Nucleic Acid Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Proteomics Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)

6. Global Ribonucleic Acid (RNA) Markers Market, By End User, 2021 - 2033, (US$ Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segments Trends
Research Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Others ( Academic Institutes, Forensic Laboratory and Others)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)

7. Global Ribonucleic Acid (RNA) Markers Market, By Region, 2021 - 2033, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Million)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Agilent Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Oxford Gene Technology IP Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
PerkinElmer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Eurofins Scientific
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
F. Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
NextGen Life Sciences Private Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
bioMerieux SA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
New England Biolabs
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Promega Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Takara Bio Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Abnova Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
QIAGEN
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Bio-Rad Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Lonza
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
CardioNet
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
ZOLL Medical Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Hill-Rom Services, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies